Showing 1,161 - 1,180 results of 10,572 for search '"Tumor"', query time: 0.07s Refine Results
  1. 1161
  2. 1162

    Effectiveness of a Patient Support Program in Supporting Access to Therapy for Solid Tumor Malignancies by Lindsay Parker, Alissa Shaul, Brian Murphy, Zeba M. Khan

    Published 2016-10-01
    “…**Objective:** To better understand the effect of patient support programs on access to therapy for solid tumor malignancies, this study evaluated service use, case outcomes, and patient characteristics from a manufacturer-sponsored program in the United States. …”
    Get full text
    Article
  3. 1163

    Reevaluating the Concept of Treating Experimental Tumors with a Mixed Bacterial Vaccine: Coley’s Toxin by C. Maletzki, U. Klier, W. Obst, B. Kreikemeyer, M. Linnebacher

    Published 2012-01-01
    “…In vivo, repetitive, local CT application was well tolerated by animals and induced considerable delay of Panc02 tumors. However, systemic treatment failed to affect tumor growth. …”
    Get full text
    Article
  4. 1164

    Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors by G. Lamberti, C. Ceccarelli, N. Brighi, I. Maggio, D. Santini, C. Mosconi, C. Ricci, G. Biasco, D. Campana

    Published 2017-01-01
    “…To evaluate the role of the activation of mTOR (phosphorylated mTOR, p-mTOR) and the expression SSTR2A and IGF-1R as prognostic factor in well-differentiated neuroendocrine tumors. Methods. A retrospective study was conducted on data from patients with diagnosis of neuroendocrine tumor originated from pancreas (pNET) or gastrointestinal tract (stomach, appendix, and ileus; GI-NET) made between January 2003 and December 2004 and followed up at our institution. …”
    Get full text
    Article
  5. 1165
  6. 1166

    Accurate identification of primary site in tumors of unknown origin (TUO) using DNA methylation by Drew Duckett, Erica R. Vormittag-Nocito, Pouya Jamshidi, Madina Sukhanova, Stephanie Parker, Daniel J. Brat, Lawrence J. Jennings, Lucas Santana-Santos

    Published 2025-01-01
    “…Abstract Tumors of unknown origin (TUO) generally result in poor patient survival and are clinically difficult to address. …”
    Get full text
    Article
  7. 1167

    A Rare Case Report: A Malignant Histiocytic Tumor in the Form of Ovarian Mass by Emsal Pinar Topdagi Yilmaz, Yakup Kumtepe, Yunus Emre Topdagi, Seray Kaya Topdagi

    Published 2018-01-01
    “…In this case report, we present a case of malignant histiocytic tumor affecting the ovary of a 40-year-old virgin female. …”
    Get full text
    Article
  8. 1168
  9. 1169

    Genetic analysis of pathways regulated by the von Hippel-Lindau tumor suppressor in Caenorhabditis elegans. by Tammie Bishop, Kah Weng Lau, Andrew C R Epstein, Stuart K Kim, Min Jiang, Delia O'Rourke, Christopher W Pugh, Jonathan M Gleadle, Martin S Taylor, Jonathan Hodgkin, Peter J Ratcliffe

    Published 2004-10-01
    “…The von Hippel-Lindau (VHL) tumor suppressor functions as a ubiquitin ligase that mediates proteolytic inactivation of hydroxylated alpha subunits of hypoxia-inducible factor (HIF). …”
    Get full text
    Article
  10. 1170

    Automated Classification of Circulating Tumor Cells and the Impact of Interobsever Variability on Classifier Training and Performance by Carl-Magnus Svensson, Ron Hübler, Marc Thilo Figge

    Published 2015-01-01
    “…Here we investigated the interobserver variability of image data comprising fluorescently stained circulating tumor cells and its effect on the performance of two automated classifiers, a random forest and a support vector machine. …”
    Get full text
    Article
  11. 1171
  12. 1172
  13. 1173
  14. 1174

    Circulating tumor DNA for surveillance in high-risk melanoma patients: a study protocol by Magnús P.B. Obinah, Sarah A. Al-Halafi, Karin Dreisig, Tim S. Poulsen, Christoffer Johansen, Thomas Litman, Stig E. Bojesen, Estrid Høgdall, Annette H. Chakera, Lisbet R. Hölmich

    Published 2025-02-01
    “…Background and purpose: Melanoma is one of the deadliest skin cancers and challenges clinicians worldwide due to rising incidence, potential aggressiveness, and propensity for metastasis, necessitating comprehensive follow-up programs after primary treatment. Circulating tumor DNA (ctDNA) is a promising biomarker that may indicate disease progression earlier than traditional surveillance methods, including 18F-FDG PET-CT, ultrasound, and clinical examination. …”
    Get full text
    Article
  15. 1175
  16. 1176

    Amyloids in bladder cancer hijack cancer-related proteins and are positive correlated to tumor stage by Diego Alem, César X. García-Laviña, Francisco Garagorry, Dardo Centurión, Joaquina Farias, Hany Pazos-Espinosa, María Noel Cuitiño-Mendiberry, Carolina Villadóniga, Susana Castro-Sowinski, Martín Fló, Federico Carrión, Brenda Iglesias, Kevin Madauss, Lucía Canclini

    Published 2025-02-01
    “…In a murine model of bladder cancer, a positive correlation was observed between amyloids and tumor stage, indicating an association between amyloids and bladder cancer progression. …”
    Get full text
    Article
  17. 1177
  18. 1178
  19. 1179

    Metastatic Malignant Ovarian Steroid Cell Tumor: A Case Report and Review of the Literature by Jessica Lee, Veena S. John, Sharon X. Liang, Catherine A. D’Agostino, Andrew W. Menzin

    Published 2016-01-01
    “…At the time of laparotomy, the tumor had already spread to the pelvic cul-de-sac. …”
    Get full text
    Article
  20. 1180